Waystar (NASDAQ:WAY) Upgraded to Strong-Buy at Barclays

Barclays upgraded shares of Waystar (NASDAQ:WAY) to a strong-buy rating in a report published on Wednesday,Zacks.com reports.

Other equities analysts have also issued research reports about the stock. Leerink Partners initiated coverage on shares of Waystar in a research report on Monday, February 2nd. They set an “outperform” rating and a $43.00 price objective on the stock. Truist Financial dropped their price target on shares of Waystar from $51.00 to $38.00 and set a “buy” rating on the stock in a research report on Wednesday, February 18th. Raymond James Financial reissued a “strong-buy” rating and issued a $32.00 price target on shares of Waystar in a research report on Thursday, April 30th. Evercore set a $27.00 price target on shares of Waystar in a research report on Wednesday, February 18th. Finally, Wall Street Zen raised shares of Waystar from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Four equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Waystar presently has an average rating of “Buy” and an average price target of $35.62.

Waystar Price Performance

Shares of WAY opened at $19.21 on Wednesday. The firm has a market cap of $3.68 billion, a PE ratio of 28.67, a PEG ratio of 0.78 and a beta of 0.21. The firm’s 50 day moving average price is $23.09 and its 200 day moving average price is $28.09. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.76 and a current ratio of 1.76. Waystar has a twelve month low of $17.89 and a twelve month high of $41.49.

Waystar (NASDAQ:WAY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.03. The firm had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. As a group, research analysts expect that Waystar will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Waystar

Several hedge funds and other institutional investors have recently modified their holdings of WAY. Root Financial Partners LLC grew its stake in shares of Waystar by 6,475.0% in the first quarter. Root Financial Partners LLC now owns 1,052 shares of the company’s stock worth $25,000 after acquiring an additional 1,036 shares during the last quarter. ANTIPODES PARTNERS Ltd grew its stake in shares of Waystar by 120.1% in the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock worth $31,000 after acquiring an additional 449 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Waystar by 6,005.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company’s stock worth $38,000 after acquiring an additional 1,141 shares during the last quarter. Danske Bank A S acquired a new stake in shares of Waystar in the fourth quarter worth $52,000. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Waystar by 3,219.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after acquiring an additional 1,352 shares during the last quarter.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.